title: Improving renal transplant outcomes in African Americans with OKT3 induction therapy.
authors.affiliation: Transplantation Services, Washington Hospital Center, Washington, DC 20010.
authors.forename: J A
authors.initials: JA
authors.lastname: Light
authors.forename: J L
authors.initials: JL
authors.lastname: Kelly
authors.forename: A
authors.initials: A
authors.lastname: Aquino
authors.forename: L
authors.initials: L
authors.lastname: Neu
authors.forename: L
authors.initials: L
authors.lastname: DeNavas
authors.forename: K
authors.initials: K
authors.lastname: Williams
mesh_terms: D000328:Adult; D001741:Black or African American; D044383:Black People; D003928:Diabetic Nephropathies / Q000601:surgery; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012086:Reoperation; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D044465:White People
chemical_list: D016853:Muromonab-CD3